Increasingly, the conventional ways of maintaining pharma equipment call for a digital alternative. Non-wear-based failures such as operating excursion and changes in operation plans make up to 80% of equipment failures.
Watch Now
Discovering new “drug-like” and synthetically viable compounds via artificial intelligence (AI) is of great interest to medicinal chemists.
Watch Now
pharmaphorum
Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the second Life Sciences Sector Deal and the long-term plan for the NHS. With these two plans in place there are plenty of opportunities for the industry and the government to work together to keep the UK at the top of the international life sciences sector – and perhaps reach even greater heights.
Watch Now
eyeforpharma
Clinical trial participants are no longer just numbers on a spreadsheet. They are customers, consumers, patients and people, with all their wonderful complexities, preferences and nuances. And they have a right to choose whether your trial is going to suit them.
Watch Now